---
title: "Alterity Therapeutics director Peter Ashley Marks acquires 47,620 shares for $0.50 each, valued at $23,810"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298373491.md"
description: "Alterity Therapeutics director Peter Ashley Marks acquired 47,620 ordinary shares at $0.50 each via Lampam Pty Ltd, totaling $23,810. This transaction increased his indirect shareholding to 191,340 shares and reduced a related listed option position for the same number of shares to zero."
datetime: "2026-09-08T23:02:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298373491.md)
  - [en](https://longbridge.com/en/news/298373491.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298373491.md)
generator: "portal-rs"
---

# Alterity Therapeutics director Peter Ashley Marks acquires 47,620 shares for $0.50 each, valued at $23,810

-   Alterity Therapeutics director Peter Ashley Marks increased indirect ownership via Lampam Pty Ltd with a purchase of 47,620 ordinary shares. \* Transaction price was $0.5 per share. \* Indirect holding in ordinary shares rose to 191,340 shares. \* Related listed option position for 47,620 shares at $0.5 was reduced to zero. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alterity Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002127888-26-000004), on September 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ATHE.US](https://longbridge.com/en/quote/ATHE.US.md)
- [ATH.AU](https://longbridge.com/en/quote/ATH.AU.md)

## Related News & Research

- [Alterity Therapeutics issues 8,400,000 shares tied to exercised options at A$ 0.5 each](https://longbridge.com/en/news/298298137.md)
- [Alterity Therapeutics Issues 8.4 Million Shares Under Underwriting Deal](https://longbridge.com/en/news/298249430.md)
- [Alterity Therapeutics issues shares from exercise of listed options at A$0.5 each](https://longbridge.com/en/news/297504784.md)
- [Alterity Therapeutics Seeks Quotation for New ASX Shares](https://longbridge.com/en/news/299120002.md)
- [Insider Move at Biotech Firm Sparks Fresh Investor Interest](https://longbridge.com/en/news/298398581.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**